Current Insights of Post-Infusion CAR T Expansion and Persistence for Large B-Cell Lymphoma
Cancers · 29.09.2025 · 17 (19) · 3167
DOI: 10.3390/cancers17193167 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 29.09.2025. Verfasst von Grace Wolyncewicz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Haematology, Royal Prince Alfred Hospital, Sydney Local Health District, Sydney, NSW 2050, Australia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
CD19 directed chimeric antigen receptor (CAR) T-cell therapy is standard of care for relapsed or refractory large B-cell lymphoma. CAR T-cell persistence and activity are associated with outcomes for patients with relapsed B-acute lymphoblastic leukaemia (B-ALL), but the association between expansion kinetics and outcome is less clear in the setting of large B-cell lymphoma. CAR T-cell expansion and persistence have been measured in both clinical trials and real-world settings, but the clinical relevance and applicability of these measurements remain unclear. There is increasing evidence that the in vivo kinetics of CAR T-cells post-infusion do offer important predictive insights into patient outcomes; despite this, limitations remain given the heterogeneity in methodology and timing of measurement. This review will summarise methodologies utilised to measure CD19 directed CAR T-cell expansion and persistence in vivo, in addition to the clinical implications of these measurements as currently described.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Haematology, Royal Prince Alfred Hospital, Sydney Local Health District, Sydney, NSW 2050, Australia.
- Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2050, Australia.
- Department of Haematology, Royal Adelaide Hospital, Adelaide, SA 5000, Australia.
Zitieren
APA
Wolyncewicz, G., Wayte, R., & Abadir, E. (2025). Current Insights of Post-Infusion CAR T Expansion and Persistence for Large B-Cell Lymphoma. Cancers, 17(19), 3167. https://doi.org/10.3390/cancers17193167
Vancouver
Wolyncewicz G, Wayte R, Abadir E. Current Insights of Post-Infusion CAR T Expansion and Persistence for Large B-Cell Lymphoma. Cancers. 2025;17(19):3167. doi:10.3390/cancers17193167
BibTeX
@article{Wolyncewicz2025,
author = {Wolyncewicz, Grace and Wayte, Rebecca and Abadir, Edward},
title = {Current Insights of Post-Infusion CAR T Expansion and Persistence for Large B-Cell Lymphoma},
journal = {Cancers},
year = {2025},
volume = {17},
number = {19},
pages = {3167},
doi = {10.3390/cancers17193167}
}
EUVIMED